FarmaKology’s Substack
Subscribe
Sign in
Home
Archive
About
Latest
Top
FarmaKology-Mushroom Supplement Found to Slow Prostate Cancer
Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy…
Nov 13
•
FarmaKology
6
Share this post
FarmaKology’s Substack
FarmaKology-Mushroom Supplement Found to Slow Prostate Cancer
Copy link
Facebook
Email
Notes
More
August 2024
FarmaKology-Nanoform Collaborates with Takeda on Plasma-derived Therapy Development
Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy…
Aug 15
•
FarmaKology
3
Share this post
FarmaKology’s Substack
FarmaKology-Nanoform Collaborates with Takeda on Plasma-derived Therapy Development
Copy link
Facebook
Email
Notes
More
June 2024
FarmaKology-Diabetes and Obesity Drugs May Reduce Risk of Dementia For Older Diabetes Patients
Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy…
Jun 24
•
FarmaKology
3
Share this post
FarmaKology’s Substack
FarmaKology-Diabetes and Obesity Drugs May Reduce Risk of Dementia For Older Diabetes Patients
Copy link
Facebook
Email
Notes
More
April 2024
FarmaKology-Artificial Intelligence Speeds Up Parkinson’s Drug Development
Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy…
Apr 22
•
FarmaKology
2
Share this post
FarmaKology’s Substack
FarmaKology-Artificial Intelligence Speeds Up Parkinson’s Drug Development
Copy link
Facebook
Email
Notes
More
February 2024
FarmaKology-Eisai Commences Fully-Fledged Business Activities at Pharma Sales Subsidiary in South Africa
Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy…
Feb 1
•
FarmaKology
3
Share this post
FarmaKology’s Substack
FarmaKology-Eisai Commences Fully-Fledged Business Activities at Pharma Sales Subsidiary in South Africa
Copy link
Facebook
Email
Notes
More
December 2023
FarmaKology-Gaza's elderly face war, displacement and medicine shortages
Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy…
Dec 18, 2023
•
FarmaKology
7
Share this post
FarmaKology’s Substack
FarmaKology-Gaza's elderly face war, displacement and medicine shortages
Copy link
Facebook
Email
Notes
More
November 2023
FarmaKology-Scientists created new antibody to combat breast cancer
Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy…
Nov 6, 2023
•
FarmaKology
8
Share this post
FarmaKology’s Substack
FarmaKology-Scientists created new antibody to combat breast cancer
Copy link
Facebook
Email
Notes
More
October 2023
FarmaKology-New deep screening technique enables rapid discovery of high-affinity antibodies to clinically relevant drug targets
Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy…
Oct 11, 2023
•
FarmaKology
4
Share this post
FarmaKology’s Substack
FarmaKology-New deep screening technique enables rapid discovery of high-affinity antibodies to clinically relevant drug targets
Copy link
Facebook
Email
Notes
More
September 2023
FarmaKology-Mendus receives U.S. FDA Fast Track Designation for vididencel in Acute Myeloid Leukemia
Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy…
Sep 8, 2023
•
FarmaKology
2
Share this post
FarmaKology’s Substack
FarmaKology-Mendus receives U.S. FDA Fast Track Designation for vididencel in Acute Myeloid Leukemia
Copy link
Facebook
Email
Notes
More
August 2023
FarmaKology-Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma
Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy…
Aug 16, 2023
•
FarmaKology
1
Share this post
FarmaKology’s Substack
FarmaKology-Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma
Copy link
Facebook
Email
Notes
More
July 2023
FarmaKology-Scientists Use AI to Discover Drugs That Kill “Zombie Cells” and Fight Age-Related Diseases
Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy…
Jul 11, 2023
•
FarmaKology
1
Share this post
FarmaKology’s Substack
FarmaKology-Scientists Use AI to Discover Drugs That Kill “Zombie Cells” and Fight Age-Related Diseases
Copy link
Facebook
Email
Notes
More
May 2023
FarmaKology-Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen
Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy…
May 19, 2023
•
FarmaKology
1
Share this post
FarmaKology’s Substack
FarmaKology-Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts